Skip to main content

Michael

Analyst

Leerink Partners

Equibles does not estimate personal net worth.

About Michael

Michael is recorded as Analyst at Leerink Partners. Michael has spoken on 9 earnings calls and 2 other investor events across 11 companies, most recently for 10x Genomics, Inc. on November 5, 2026. Those appearances were for 10x Genomics, Inc. (TXG), Prospect Capital Corp (PSEC), FUCHS SE, Cogent Communications Holdings, Inc. (CCOI), Lantern Pharma Inc. (LTRN) and 6 other companies. The companies whose calls Michael spoke on are classified in the Healthcare, Financial Services, Basic Materials and Communication Services sectors.

Michael on recent calls

“I think I wanted to pivot the conversation to a single cell. Could you offer any color on the APEX transition, like how far along we are there? I know you've also talked about APEX being the most, or the flex.”
Analyst — Leerink Partners, 10x Genomics Third Quarter 2026 Earnings Conference Call ·
“Good day, and welcome to the Prospect Capital First Quarter 2027 Earnings Release and Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal Conference Specialist by pressing the star key followed by zero.”
Host, Prospect Capital Corp Q1 FY2027 Earnings Call ·
“The first one is looking into your organic growth, which you have reported in the third quarter, and my understanding is it's largely price-driven. However, we see some regional differences.”
Analyst — Leerink Partners, Analyst's Conference Call - 9M 2026 Results ·
“We're going to start with to have Dave Schaefer from Cogent here with us. He's kind enough to come every year, and great to hear the latest from you, Dave. So thank you again.”
Analyst — Leerink Partners, 2026 BofA Securities Media, Communications & Entertainment Conference ·
“Two questions, Pana, one on LP300 and then the other on OMAI. Just on LP300, can you talk about where are you in the data analysis? It's obviously nice to see the PFS stretching out a little bit more, but how mature is this data set?”
Analyst — Leerink Partners, Lantern Pharma Inc. Q2 FY2026 Earnings Call ·

Affiliation history

  • Leerink Partners

    Analyst

    Source not stated

    Current

Company network

FUCHS SE

Specialty Chemicals · Basic Materials

1 appearance Latest appearance 2026-10-30

STANDARD LIFE PLC

Insurance - Life · Financial Services

1 appearance Latest appearance 2026-03-16

AMUNDI

Asset Management · Financial Services

1 appearance Latest appearance 2026-02-03

Recent activity